TOP HEADLINES

Featured Story

  • Patterson posts record quarterly results amid shift toward animal health

    Minnesota-based distributor Patterson Companies reported record fiscal fourth-quarter results Thursday that were boosted by its fast-growing animal health unit. The company's sales rose 4% year-over-year to $1.1 billion, while its net income came in at $64.5 million ($0.65 per diluted share), compared to $55.7 million ($0.55) in the same period a year ago.

Animal health, production in St. Joseph, MO, ranks fourth in U.S. metro ag economies

According to a recent analysis of the largest agriculture centers in the U.S., St. Joseph, MO ranked fourth due to its strength in animal production and its location as part of what is marketed as the Kansas City Animal Health Corridor.

Wal-Mart hailed for leadership on animal welfare

Retailing giant Wal-Mart ($WMT) drew praise from animal welfare activists Friday when it announced voluntary guidelines for its meat and egg suppliers that would reduce the use of antibiotics on farms and improve conditions for livestock and poultry.

Bionic turtle offers glimpse into future of 3-D printing

An endangered loggerhead sea turtle injured in a boating accident off the coast of Turkey has been given a lifesaving prosthetic jaw that offers a glimpse of how 3-D printing is revolutionizing veterinary care.

Patterson posts record quarterly results amid shift toward animal health

Minnesota-based distributor Patterson Companies reported record fiscal fourth-quarter results Thursday that were boosted by its fast-growing animal health unit. The company's sales rose 4% year-over-year to $1.1 billion, while its net income came in at $64.5 million ($0.65 per diluted share), compared to $55.7 million ($0.55) in the same period a year ago.

Chicken producer Sanderson says FDA's crackdown on antibiotics lacks 'reliable science'

Joe Sanderson, CEO of chicken producer Sanderson Farms, says he's telling his chicken farmers to continue using antibiotics to treat sick birds and prevent illnesses, because he believes FDA's concerns are overblown, according to the Wall Street Journal.

MORE NEWS

From Our Sister Sites

FierceBiotech

Bavarian Nordic has downplayed its interest in becoming the latest European biotech to be scooped up by a deep-pocketed suitor. The vaccine player has regained some of its luster over the past year through deals with Bristol-Myers Squibb and Johnson & Johnson, but has no desire to cash in on its moment in the limelight.

FierceCRO

U.K. CRO Ergomed is expanding its share of the postmarketing services business, buying a medical information firm that fields patient queries for drug companies.